Media Kit

Here are resources for members of the media. If you have any questions or wish to schedule an interview, please contact our media team.

CPFF Board of Directors

Executive Director, Canadian Pulmonary Fibrosis

Board Chair, Alberta, Canadian Pulmonary Fibrosis

Board Member, Canadian Pulmonary Fibrosis

Medical Professionals

Chair of CPFF Medical Advisory Council, Founding Chair of Canadian Thoracic Society’s Clinical Assembly on Interstitial Lung Diseases, Director of the University of Calgary Interstitial Lung Disease Program

Dr. Matthew Binnie is an Assistant Professor at the University of Toronto and Staff Physician at the Toronto Lung Transplant Program and TGH Interstitial Lung Diseases Clinic as well as St Michael’s Hospital.

CPFF Board of Directors, Respirologist and Assistant Professor of Medicine in Respirology at Memorial University in St. John’s, Newfoundland.

Respirologist, Director of the Interstitial Lung Disease Clinic and Lung Transplant Clinic of Toronto General Hospital.

Patients and Caregivers

Patient, Manitoba
Previously very active. Misdiagnosed. Recent lung recipient.

Patient, Ontario
Extremely long road to diagnosis.

Patient, Nova Scotia
Impacted by limited access to diagnosis and care

Patient, CPFF Board of Directors
Living with pulmonary fibrosis.

Press Release

September 6, 2022

Oxygen unacceptably scarce for some Canadians

20% of pulmonary fibrosis patients experience delays in accessing oxygen when they need it, survey finds.

For the more than 30,000 Canadians living with pulmonary fibrosis (PF), an incurable and fatal lung disease, each day presents a new challenge. Today, the Canadian Pulmonary Fibrosis Foundation (CPFF) released a snapshot of its 2022 Patient and Caregiver Survey results. The survey highlights the many challenges that pulmonary fibrosis (PF) patients continue to face, but most notably, that oxygen is unacceptably scarce for PF patients – 20% of patients did not get an oxygen therapy prescription when they needed it. Download the press release.